Help Patients With Skyrocketing Insulin Costs

August 2019

One in four patients with diabetes will ration or even stop their insulin due to skyrocketing costs...sometimes leading to death.

In the U.S., only 3 companies make insulin...driving up prices.

You'll see more efforts to address costs...such as co-pay caps from some payers and states. And FDA is exploring ways to promote competition.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote